Growth Metrics

AtriCure (ATRC) Gains from Investment Securities (2016 - 2025)

AtriCure (ATRC) has disclosed Gains from Investment Securities for 16 consecutive years, with $228000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 18.75% to $228000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.2 million through Dec 2025, up 60.6% year-over-year, with the annual reading at $11.2 million for FY2025, 60.6% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $228000.0 at AtriCure, down from $357000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $184.8 million in Q3 2021, with the low at -$5.6 million in Q2 2023.
  • Average Gains from Investment Securities over 5 years is $12.4 million, with a median of $449000.0 recorded in 2024.
  • The sharpest move saw Gains from Investment Securities skyrocketed 62658.82% in 2022, then crashed 694.88% in 2023.
  • Over 5 years, Gains from Investment Securities stood at $184.8 million in 2021, then tumbled by 99.96% to $65000.0 in 2022, then increased by 29.23% to $84000.0 in 2023, then skyrocketed by 128.57% to $192000.0 in 2024, then grew by 18.75% to $228000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $228000.0, $357000.0, and $406000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.